These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 12047482

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
    Anschütz M, Wonnemann M, Schug B, Toal C, Donath F, Pontius A, Pauli K, Brendel E, Blume H.
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
    [Abstract] [Full Text] [Related]

  • 3. Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.
    Wonnemann M, Schug B, Schmücker K, Brendel E, van Zwieten PA, Blume H.
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):38-48. PubMed ID: 16425970
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union.
    Schug BS, Brendel E, Wolf D, Wonnemann M, Wargenau M, Blume HH.
    Eur J Pharm Sci; 2002 Apr; 15(3):279-85. PubMed ID: 11923060
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relative bioavailability of four controlled-release nifedipine products.
    Schall R, Müller FO, Hundt HK, Duursema L, Groenewoud G, Van Dyk M, Van Schalkwyk AM.
    Biopharm Drug Dispos; 1994 Aug; 15(6):493-503. PubMed ID: 7993987
    [Abstract] [Full Text] [Related]

  • 11. Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food.
    Abrahamsson B, Alpsten M, Bake B, Jonsson UE, Eriksson-Lepkowska M, Larsson A.
    J Control Release; 1998 Mar 31; 52(3):301-10. PubMed ID: 9743450
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and Bioequivalence of 2 Nifedipine Controlled-Release Tablets: A Randomized, Single-Dose, 2-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
    Xin L, Chen Q, Chen D, Li Y, Li Y, Wu Q, Zou Y, Wang W, Jia J, Yu C, Liu Y.
    Clin Pharmacol Drug Dev; 2023 Nov 31; 12(11):1082-1088. PubMed ID: 37132398
    [Abstract] [Full Text] [Related]

  • 14. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL, Forbes WP.
    Clin Pharmacokinet; 1999 Nov 31; 37 Suppl 2():13-23. PubMed ID: 10702883
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of a new once-daily controlled-release formulation of aceclofenac in Korean healthy subjects compared with immediate-release aceclofenac and the effect of food: a randomized, open-label, three-period, crossover, single-centre study.
    Bae SK, Kim SH, Lee HW, Seong SJ, Shin SY, Lee SH, Lim MS, Yoon YR, Lee HJ.
    Clin Drug Investig; 2012 Feb 01; 32(2):111-9. PubMed ID: 22149151
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine.
    Kinzler ER, Pantaleon C, Iverson M, Aigner S.
    Adv Ther; 2019 Sep 01; 36(9):2394-2401. PubMed ID: 31278694
    [Abstract] [Full Text] [Related]

  • 19. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
    Bass A, Stark JG, Pixton GC, Sommerville KW, Zamora CA, Leibowitz M, Rolleri R.
    Clin Ther; 2012 Jul 01; 34(7):1601-12. PubMed ID: 22717418
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.